V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310002628 | 310001115 | 1.86 | 87 | Palliative (P) | 2015-12-27 | 2016-01-06 | CISPLATIN + GEMCITABINE | 02 | N | 310015584 | CISPLATIN + GEMCITABINE |
| 310002629 | 310001115 | 1.73 | 77 | Not known (9) | 2015-07-31 | 2015-08-07 | Trial Unspecified | Y | N | 310015584 | TRIAL |
| 310002630 | 310010262 | 1.64 | 85.1 | Curative (C) | 2015-12-01 | 2015-12-04 | CHOP R - 21 days | N | N | 310015594 | CHOP R |
| 310002631 | 310010262 | null | 70.8 | null | 2017-09-30 | 2017-09-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310015594 | CISPLATIN + GEMCITABINE |
| 310002632 | 310010262 | null | 65.25 | Palliative (P) | 2018-01-05 | 2018-01-05 | Ipilimumab | 02 | N | 310015594 | IPILIMUMAB |
| 310002633 | 310010262 | 0 | null | Adjuvant (A) | 2013-09-12 | 2013-09-15 | Retinoblastoma JOE | 02 | N | 310015594 | CEV |
| 310002634 | 310001116 | null | 57.3 | Curative (C) | 2015-08-29 | 2015-09-08 | CHOP R | 02 | N | 310015609 | CHOP R |
| 310002635 | 310006414 | 1.8 | 12.5 | null | 2013-04-29 | 2013-05-12 | Carboplatin + Etoposide iv&po | N | N | 310015611 | CARBOPLATIN + ETOPOSIDE |
| 310002637 | 310006415 | 1.74 | 69 | Palliative (P) | 2017-09-16 | 2017-10-01 | Carboplatin + Etoposide iv&po | N | N | 310015613 | CARBOPLATIN + ETOPOSIDE |
| 310002638 | 310006415 | 1.9 | 57.7 | Neo-adjuvant (N) | 2013-08-08 | 2013-09-04 | CISPLATIN + GEMCITABINE | N | N | 310015613 | CISPLATIN + GEMCITABINE |
| 310002640 | 310006416 | 1.9 | 64 | Neo-adjuvant (N) | 2013-02-21 | 2013-02-22 | CHEMO-T TRIAL | Y | null | 310015624 | TRIAL |
| 310002641 | 310006416 | 1.51 | null | Palliative (P) | 2015-06-18 | 2015-06-18 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310015624 | CISPLATIN + GEMCITABINE |
| 310002642 | 310001119 | 1.72 | 60.5 | Adjuvant (A) | 2016-06-15 | 2016-06-15 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015634 | CISPLATIN + GEMCITABINE |
| 310002643 | 310006417 | 1.65 | 71.7 | Not known (9) | 2017-07-14 | 2017-07-14 | CHOP R - 21 days | N | N | 310015639 | CHOP R |
| 310002644 | 310001120 | 1.83 | 68.1 | Palliative (P) | null | 2015-12-10 | Cisplatin 7 day | null | Y | 310015647 | CISPLATIN |
| 310002645 | 310006418 | 1.75 | 61.7 | Palliative (P) | 2015-10-07 | 2015-10-07 | Doxorubicin 75mg/m2 | 02 | N | 310015652 | DOXORUBICIN |
| 310002646 | 310008930 | null | 66 | Palliative (P) | 2016-12-02 | 2016-12-11 | PEMBROLIZUMAB | 02 | N | 310015654 | PEMBROLIZUMAB |
| 310002647 | 310008930 | 1.76 | 85 | Palliative (P) | 2016-05-04 | 2016-05-16 | PEMBROLIZUMAB | 02 | N | 310015654 | PEMBROLIZUMAB |
| 310002648 | 310008930 | 1.59 | 60.4 | Palliative (P) | 2015-09-16 | 2015-09-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310015654 | CISPLATIN + GEMCITABINE |
| 310002649 | 310001121 | 1.77 | 60.5 | Palliative (P) | 2016-02-28 | 2016-03-10 | Ipilimumab | N | N | 310015659 | IPILIMUMAB |
| 310002650 | 310001121 | null | 77 | Palliative (P) | 2014-07-03 | 2014-07-07 | DOXORUBICIN | N | N | 310015659 | DOXORUBICIN |
| 310002651 | 310001121 | 1.67 | null | Palliative (P) | 2016-11-24 | 2016-11-24 | Trial Unspecified | 1 | N | 310015659 | TRIAL |
| 310002653 | 310006420 | 1.78 | 4.3 | Palliative (P) | 2016-09-20 | 2016-10-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310015674 | CISPLATIN + GEMCITABINE |
| 310002654 | 310008932 | 1.7 | 97.4 | Palliative (P) | 2018-06-18 | 2018-06-25 | CISPLATIN + GEMCITABINE | 02 | N | 310015683 | CISPLATIN + GEMCITABINE |
| 310002655 | 310001123 | 1.47 | 91.099 | Curative (C) | null | 2016-06-04 | CHEMO-T TRIAL | 1 | null | 310015687 | TRIAL |
| 310002656 | 310001123 | 1.79 | 24.9 | Palliative (P) | 2017-02-18 | 2017-02-18 | Trial Unspecified | N | null | 310015687 | TRIAL |
| 310002658 | 310001125 | 1.75 | 56 | Palliative (P) | 2016-11-07 | 2016-11-26 | PEMBROLIZUMAB | N | N | 310015694 | PEMBROLIZUMAB |
| 310002659 | 310001126 | 1.7 | 97.1 | null | 2017-07-08 | 2017-07-23 | CHOP R - 21 days | N | N | 310015697 | CHOP R |
| 310002660 | 310006422 | null | null | Palliative (P) | 2016-05-08 | 2016-05-22 | Ipilimumab | null | N | 310015703 | IPILIMUMAB |
| 310002661 | 310001127 | 1.85 | null | Palliative (P) | 2018-06-13 | 2018-06-14 | PEMBROLIZUMAB | N | N | 310015706 | PEMBROLIZUMAB |
| 310002662 | 310001127 | 1.59 | 59 | Palliative (P) | 2016-12-26 | 2016-12-26 | CISPLATIN + GEMCITABINE | 2 | N | 310015706 | CISPLATIN + GEMCITABINE |
| 310002663 | 310001127 | null | 53.3 | Palliative (P) | 2017-07-20 | 2017-07-20 | PEMBROLIZUMAB | 02 | N | 310015706 | PEMBROLIZUMAB |
| 310002664 | 310001127 | 1.57 | 64.9 | Palliative (P) | 2017-02-13 | 2017-02-17 | PEMBROLIZUMAB | 02 | N | 310015706 | PEMBROLIZUMAB |
| 310002665 | 310001127 | 1.71 | 89 | Palliative (P) | null | 2014-03-03 | PEMBROLIZUMAB | 02 | N | 310015706 | PEMBROLIZUMAB |
| 310002666 | 310001127 | 1.75 | null | Palliative (P) | 2016-01-05 | 2016-01-07 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | N | 310015706 | CISPLATIN + GEMCITABINE |
| 310002667 | 310011647 | 1.85 | null | null | 2013-02-16 | 2013-03-03 | Cisplatin | N | N | 310015728 | CISPLATIN |
| 310002668 | 310001128 | null | 11.64 | Curative (C) | 2015-08-23 | 2015-09-04 | CHOP R - 21 days | N | N | 310015731 | CHOP R |
| 310002669 | 310001129 | null | null | Curative (C) | 2016-05-28 | 2016-05-28 | Retinoblastoma JOE | N | N | 310015734 | CEV |
| 310002670 | 310001129 | 1.61 | null | Palliative (P) | 2016-07-16 | 2016-07-16 | CARBOPLATIN + ETOPOSIDE | N | N | 310015734 | CARBOPLATIN + ETOPOSIDE |
| 310002671 | 310001130 | null | 51.2 | Curative (C) | 2014-06-02 | 2014-06-02 | Carboplatin + Etoposide iv&po | 02 | N | 310015741 | CARBOPLATIN + ETOPOSIDE |
| 310002672 | 310001130 | null | 80 | null | 2017-06-13 | 2017-06-12 | CHOP R - 21 days | 2 | N | 310015741 | CHOP R |
| 310002673 | 310001131 | null | 81.5 | Palliative (P) | 2015-04-08 | 2015-04-27 | CHOP R - 21 days | 02 | N | 310015747 | CHOP R |
| 310002674 | 310001132 | 1.8 | 64.9 | Curative (C) | 2016-09-06 | 2016-09-15 | Cisplatin | N | Y | 310015751 | CISPLATIN |
| 310002675 | 310001132 | 1.61 | 70.7 | Curative (C) | 2013-04-16 | 2013-04-17 | Cisplatin | 02 | N | 310015751 | CISPLATIN |
| 310002676 | 310001132 | 1.76 | 67.6 | Neo-adjuvant (N) | null | 2014-03-16 | CISPLATIN + GEMCITABINE | N | N | 310015751 | CISPLATIN + GEMCITABINE |
| 310002677 | 310010265 | 1.64 | 63 | Palliative (P) | 2015-10-27 | 2015-11-15 | DOXORUBICIN | N | null | 310015756 | DOXORUBICIN |
| 310002678 | 310010265 | 1.7 | null | Adjuvant (A) | 2017-07-14 | 2017-07-14 | Carboplatin + Etoposide iv&po | N | null | 310015756 | CARBOPLATIN + ETOPOSIDE |
| 310002679 | 310001133 | 1.66 | 51.8 | Palliative (P) | null | 2016-04-30 | Doxorubicin 75mg/m2 | N | N | 310015767 | DOXORUBICIN |
| 310002680 | 310001134 | 1.64 | 93.1 | Palliative (P) | 2015-07-28 | 2015-08-04 | Ipilimumab | 2 | N | 310015770 | IPILIMUMAB |
| 310002681 | 310001135 | 1.63 | 11.64 | Adjuvant (A) | 2016-08-27 | 2016-10-07 | Trial Unspecified | 01 | N | 310015777 | TRIAL |